| Thyroid Gland Neoplasm studied in …STUDIED_INderived200 of 891show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991738Phase 1/Phase 2 · not yet recruiting 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216732recruiting Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07142005recruiting Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05575440terminated Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475989Phase 3 · recruiting Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339478completed Does Parathyroid Autofluorescence Reduces Unintensional Parathyroidectomy During Total Thyroidectomy With Central Lymph Node Compartment Dissection · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822880Phase 4 · not yet recruiting A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005654recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660984active not recruiting Natural History Study of Children and Adults With Medullary Thyroid Cancer · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03765333recruiting GETNE Registration of Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522570NA · completed Thermal Ablation of Cervical Metastases From Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07428057recruiting Postoperative Hypocalcemia After Thyroidectomy · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06507878recruiting Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment. · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04040673withdrawn RAman For Thyroid cancER · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04544111Phase 2 · active not recruiting PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04467021NA · active not recruiting Cancer and Blood Pressure Management, CARISMA Study · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04927416Phase 2 · recruiting The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05786924Phase 1/Phase 2 · recruiting Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235216Phase 2 · recruiting Sacituzumab govitEcan in THYroid Cancers · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07140757recruiting Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822217active not recruiting Patients With a Single, Small (2 cm or Less) Cancer Nodule in the Thyroid Gland Will be Offered Active Surveillance Initially for 5 Years. In Case of Cancer Growth or Changes in Ultrasonographic Appearance, Further Treatment Will be Offered. · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823439not yet recruiting Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823543NA · not yet recruiting Educational Videos for Thyroid Surgery Patient · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104529NA · recruiting Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06796348NA · recruiting Radiofrequency Ablation Versus Hemithyroidectomy for Small Thyroid Cancers · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00467506Phase 2 · completed Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01709292Phase 2 · active not recruiting Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04285476NA · active not recruiting Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181720Phase 1 · suspended CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218315NA · recruiting Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03647358Phase 1 · recruiting Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557045Phase 1 · active not recruiting A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707401NA · recruiting Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812779not yet recruiting Thyroid Health Outcomes Registry for Surgery · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03841617Phase 2 · recruiting The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05119296Phase 2 · active not recruiting Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06902376Phase 1 · recruiting XL092 and Cemiplimab in BRAF WT Thyroid Cancer · condition mapped PROBABILISTIC · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06959511Phase 2 · recruiting Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07459283early Phase 1 · recruiting The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334069recruiting Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864144Phase 1/Phase 2 · completed A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07485569Phase 1 · active not recruiting Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · condition mapped PROBABILISTIC · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05355701Phase 1 · active not recruiting A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538130Phase 1 · active not recruiting A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07690839NA · not yet recruiting Pre-Clinic Visit Online Education for Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001160recruiting Studies on Tumors of the Thyroid · condition mapped PROBABILISTIC · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152995Phase 2 · active not recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07524777NA · completed Ganoderma Spores Modulate the Gut-Brain Axis · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568267Phase 2 · active not recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05241834Phase 1 · completed A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776262NA · recruiting Safety and Efficacy of Cryoablation for Thyroid Tumors · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07777536Phase 2 · recruiting Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931743NA · recruiting The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07440290Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05025046completed NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05453799Phase 2 · suspended Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07752277completed Quantitative Pharmacology-Based Dose Adjustment Protocol in Postoperative Thyroid Cancer Patients · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936858Phase 2 · completed RAD001 for Patients With Radioiodine Refractory Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657551Phase 2 · completed A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07496684completed Application and Evaluation of Vision-LSTM Modeling in Diagnostic Ultrasound Imaging of TI-RADS Category 4b Thyroid Nodules · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03215095early Phase 1 · active not recruiting RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04675710Phase 2 · active not recruiting Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05591092terminated Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Follicular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07059507recruiting Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy. · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652450NA · completed Incidental Thyroid Cancer in Cases With Inflammatory Thyroid Lesion · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04171622Phase 2 · active not recruiting Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623801Phase 2 · active not recruiting Laser Ablation of Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738888recruiting Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255482completed Mortality Benefit of Ultrasound for Thyroid Nodules Identified With PET Imaging: Non-Inferiority Emulated Target Trial · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704658Phase 4 · recruiting Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07755423enrolling by invitation Stereotactic Body Radiotherapy for the Treatment of Distant Metastases in Thyroid Cancer: A Phase II Prospective Clinical Study · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04280081Phase 2 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06498674NA · completed AI-Assisted Ultrasound Review Before Thyroid Surgery · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07753499NA · recruiting Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01412762active not recruiting Measuring Patient Expectations for Thyroid Surgery · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07713901enrolling by invitation Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225309NA · recruiting A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03099356Phase 2 · recruiting Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914300Phase 2 · active not recruiting Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259304active not recruiting Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07470489Phase 2 · not yet recruiting Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01833650NA · completed The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03181100Phase 2 · active not recruiting Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06411834NA · not yet recruiting Mapping Patient Decision-making in Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06458036Phase 2 · recruiting Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) · condition mapped PROBABILISTIC · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04877613Phase 1 · active not recruiting GFRα4 CAR T Cells in MTC Patients · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01141309Phase 2 · active not recruiting Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07234539NA · enrolling by invitation Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04139096completed Genetic Susceptibility to Radiation Induced Thyroid Cancer · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03892993NA · recruiting Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07521670Phase 2 · not yet recruiting Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705074Phase 1/Phase 2 · not yet recruiting FAPI PET Imaging - An Exploratory Study · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302672NA · recruiting Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07695974completed Clinicopathological Predictors of Recurrence in Papillary Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06958601completed Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07545837NA · recruiting Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Follicular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03085056early Phase 1 · active not recruiting Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03345563NA · completed Project HERO: Health Empowerment & Recovery Outcomes · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04238624Phase 2 · active not recruiting Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer · condition mapped PROBABILISTIC · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07406087NA · recruiting Navigation Intervention for Adolescent and Young Adult Cancer Survivors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01813136Phase 2 · completed Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04000880NA · completed Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02185560active not recruiting Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04892303Phase 1 · recruiting Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02856347NA · completed Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06959641Phase 2 · recruiting XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03285230active not recruiting The French E3N Prospective Cohort Study · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04290663Phase 3 · recruiting Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529080NA · not yet recruiting Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07659717completed Frozen Section-Guided Selective Ipsilateral Central Neck Dissection in Bethesda V-VI Thyroid Nodules · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06007924Phase 2 · recruiting A Study of Avutometinib and Defactinib in People With Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661420Phase 1 · not yet recruiting 211At-MABG in Adults With Advanced Neuroendocrine Cancers · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05708950Phase 1/Phase 2 · completed A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06961084Phase 2 · recruiting Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172921recruiting Environmental Factors and Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07654322not yet recruiting Clinical Study on the Efficacy of Laparoscopic Assisted Open Surgery Through Subclavian Approach for Unilateral Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07600580Phase 4 · recruiting The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Response · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02747888NA · recruiting Hereditary Risk Factors for Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07506161completed Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07634978NA · recruiting Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03196518NA · active not recruiting Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628543not yet recruiting Computer Vision-Based Recognition of Parathyroid Glands and Recurrent Laryngeal Nerves in Endoscopic Surgery · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630363Phase 1/Phase 2 · not yet recruiting PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04566393available Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623005NA · completed Progressive Muscle Relaxation for Pain and Quality of Life in Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621146not yet recruiting A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07068542NA · recruiting Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584447not yet recruiting Clinical Utility of Preoperative Thyroid GuidePx® Testing · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06851663Phase 2/Phase 3 · recruiting Trop2-targeted immunoPET Imaging of Solid Tumors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514484Phase 1 · active not recruiting Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465017NA · terminated ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07612293NA · not yet recruiting STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449108Phase 2 · active not recruiting LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Poorly Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04589624Phase 1 · recruiting An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759911Phase 2 · active not recruiting Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07376837NA · recruiting Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01552434Phase 1 · terminated Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00510640Phase 2 · completed Thyroid Cancer and Sunitinib · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01947023Phase 1 · active not recruiting Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06673329Phase 1 · recruiting Brodalumab in the Treatment of Immune-Related Adverse Events · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01704586NA · active not recruiting I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07575243completed Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) Protocol · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01398085Phase 2/Phase 3 · active not recruiting IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02609685NA · recruiting Active Surveillance of Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730321recruiting Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS) · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239194Phase 1/Phase 2 · recruiting Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06899347NA · not yet recruiting The Role of Prophylactic Central Compartment Neck Dissection in the Management of 2 to 4 cm Papillary Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02088645Phase 1 · active not recruiting 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03624751active not recruiting Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05265819NA · completed Effect of Exergaming Exercises and Mediterranean Diet on Thyroid Cancer Patients Following Total Thyroidectomy · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03484884active not recruiting A Study of Optical Imaging With Light From Radiotracers in Cancer Patients · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05733013recruiting A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06356272recruiting Oropharynx (OPX) Biomarker Trial · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07543887completed Selpercatinib and Body Composition · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07532356not yet recruiting Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298323Phase 3 · completed Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02713269Phase 2 · active not recruiting Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07536412NA · not yet recruiting Decision Aid Efficacy in Low Risk Thyroid Cancer · condition mapped PROBABILISTIC · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03157128Phase 1/Phase 2 · active not recruiting A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04693377NA · recruiting Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03483337recruiting New MRI Biomarkers in Head and Neck Cancers · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04061980Phase 2 · active not recruiting Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04948437active not recruiting Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05463107active not recruiting Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05696548Phase 2 · active not recruiting Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION) · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03975231Phase 1 · recruiting Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158360recruiting An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T) · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234113Phase 1 · terminated Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207188recruiting Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06146764recruiting CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06220656NA · recruiting TRAIL Study: Feasibility and Pilot · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488858NA · completed Thyroidectomy: Microscopic Versus Conventional · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03420963Phase 1 · terminated Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06316895recruiting The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211337Phase 3 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07092514Phase 2 · recruiting Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC) · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07473518recruiting Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03360890Phase 2 · active not recruiting Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03753919Phase 2 · terminated Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial · condition mapped CURATED_BROADER · 891 trials mapped (298 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04742608recruiting Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 891 trials mapped (298 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03570021Phase 3 · active not recruiting ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03573960Phase 4 · completed A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07447089NA · recruiting EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study · condition mapped ALIAS · 891 trials mapped (298 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524167recruiting RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06554652Phase 3 · recruiting Selective Neck Dissection Versus Modified Neck Dissection in PTC · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06558981Phase 3 · recruiting Adjuvant Radiotherapy in High Risk Locally Advanced DTC · condition mapped CURATED_EXACT · 891 trials mapped (298 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |